O Lahtinen1,2, M Eloranta3,4, M Anttila3,4,5, H Kärkkäinen3,4, R Sironen4,6,7, R Vanninen8,9, S Rautiainen8,9. 1. Diagnostic Imaging Centre, Department of Clinical Radiology, Kuopio University Hospital, PO Box 100, FI-70029, Kuopio, Finland. olli.lahtinen@kuh.fi. 2. Institute of Clinical Medicine, Unit of Radiology, University of Eastern Finland, Kuopio, Finland. olli.lahtinen@kuh.fi. 3. Department of Gynaecology and Obstetrics, Kuopio University Hospital, Kuopio, Finland. 4. Cancer Center of Eastern Finland, Kuopio, Finland. 5. Institute of Clinical Medicine, School of Medicine, Gynaecology, University of Eastern Finland, Kuopio, Finland. 6. Institute of Clinical Medicine/Clinical Pathology, University of Eastern Finland, Kuopio, Finland. 7. Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. 8. Diagnostic Imaging Centre, Department of Clinical Radiology, Kuopio University Hospital, PO Box 100, FI-70029, Kuopio, Finland. 9. Institute of Clinical Medicine, Unit of Radiology, University of Eastern Finland, Kuopio, Finland.
Abstract
OBJECTIVE: To evaluate the feasibility and diagnostic performance of intradermal contrast-enhanced ultrasound (CEUS) sentinel lymph node (SLN) procedure in vulvar cancer. METHODS: Twelve consecutive patients with vulvar cancer underwent preoperatively inguinal CEUS SLN examination and guide wire marking of the enhanced lymph nodes. Altogether, 20 groins were examined with CEUS contrast agent injections including 8 bilateral groins due to midline tumours. One groin was excluded due to previous inguinal surgery. The results of the CEUS examinations were compared to conventional SLN biopsy using radiocolloid scintigraphy and/or methylene blue dye and final postoperative histopathology. RESULTS: The inguinal sentinel CEUS procedure had a technical success rate of 94.7% (18/19 injections) for identifying a potential inguinal SLN. Conventional SLN biopsy using lymphoscintigraphy and/or methylene blue dye was successfully performed in 16 groins. Compared to conventional SLN biopsy, the overall sensitivity was 81.2% (13/16 injections). Additionally, CEUS detected enhancing SLNs in two cases when traditional SLN procedure failed to do so. All metastatic SLNs (n = 5) were correctly identified by CEUS procedure. CONCLUSIONS: Intradermal CEUS SLN localization can be applied in the inguinal lymphatic region in patients with vulvar cancer. Further studies are needed to verify the clinical value of this method. KEY POINTS: • CEUS is a feasible method for inguinal SLN detection in vulvar cancer • All metastatic inguinal SLNs were identified by CEUS procedure • Further studies are needed to verify the clinical value of this method.
OBJECTIVE: To evaluate the feasibility and diagnostic performance of intradermal contrast-enhanced ultrasound (CEUS) sentinel lymph node (SLN) procedure in vulvar cancer. METHODS: Twelve consecutive patients with vulvar cancer underwent preoperatively inguinal CEUS SLN examination and guide wire marking of the enhanced lymph nodes. Altogether, 20 groins were examined with CEUS contrast agent injections including 8 bilateral groins due to midline tumours. One groin was excluded due to previous inguinal surgery. The results of the CEUS examinations were compared to conventional SLN biopsy using radiocolloid scintigraphy and/or methylene blue dye and final postoperative histopathology. RESULTS: The inguinal sentinel CEUS procedure had a technical success rate of 94.7% (18/19 injections) for identifying a potential inguinal SLN. Conventional SLN biopsy using lymphoscintigraphy and/or methylene blue dye was successfully performed in 16 groins. Compared to conventional SLN biopsy, the overall sensitivity was 81.2% (13/16 injections). Additionally, CEUS detected enhancing SLNs in two cases when traditional SLN procedure failed to do so. All metastatic SLNs (n = 5) were correctly identified by CEUS procedure. CONCLUSIONS: Intradermal CEUS SLN localization can be applied in the inguinal lymphatic region in patients with vulvar cancer. Further studies are needed to verify the clinical value of this method. KEY POINTS: • CEUS is a feasible method for inguinal SLN detection in vulvar cancer • All metastatic inguinal SLNs were identified by CEUS procedure • Further studies are needed to verify the clinical value of this method.
Authors: Susan O'Mahony; Chandra K Solanki; Robert W Barber; Peter S Mortimer; Arnie D Purushotham; A Michael Peters Journal: AJR Am J Roentgenol Date: 2006-05 Impact factor: 3.959
Authors: Ali R Sever; Philippa Mills; Jennifer Weeks; Susan E Jones; David Fish; Peter A Jones; Willem Mali Journal: AJR Am J Roentgenol Date: 2012-08 Impact factor: 3.959
Authors: Patricia L Judson; Elizabeth B Habermann; Nancy N Baxter; Sara B Durham; Beth A Virnig Journal: Obstet Gynecol Date: 2006-05 Impact factor: 7.661
Authors: Ali R Sever; Philippa Mills; Susan E Jones; Karina Cox; Jennifer Weeks; David Fish; Peter A Jones Journal: AJR Am J Roentgenol Date: 2011-02 Impact factor: 3.959
Authors: L Rubaltelli; V Beltrame; E Scagliori; E Bezzon; A C Frigo; M Rastrelli; R Stramare Journal: Ultraschall Med Date: 2013-07-16 Impact factor: 6.548
Authors: Ibrahim Alkatout; Melanie Schubert; Nele Garbrecht; Marion Tina Weigel; Walter Jonat; Christoph Mundhenke; Veronika Günther Journal: Int J Womens Health Date: 2015-03-20